Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04744571
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT04744571
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04744571. Randomized; no masking; primary purpose treatment. Start 2021-02 (anticipated); primary completion 2022-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
- Condition
- Coronary Artery Disease
- Condition
- Coronary Occlusion
- Condition
- Percutaneous Coronary Intervention
- Condition
- Chronic Total Occlusion of Coronary Artery
- Condition
- Drug-Eluting Stents
- Intervention (Drug)
- aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
- Intervention (Device)
- coronary wires. or coronary balloons
- Intervention (Other)
- drug-coated balloon
- Intervention (Device)
- drug-eluting stent
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct04744571- Content hash
24865be8c789f4a661b61a4a0d62babf50c696f5374a599add11e00ed66ee598